Browsing by Author "McNeish, I."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item ENGOT-EN9/LEAP-001: A PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB PLUS LENVATINIB COMPARED WITH CHEMOTHERAPY IN ADVANCED OR RECURRENT ENDOMETRIAL CANCER(2020) Randall, L.; Marth, C.; Vulsteke, C.; Rubio, M. Jesus; Makker, V.; Braicu, I.; McNeish, I.; Madry, R.; Ayhan, A.; Hasegawa, K.; Wu, X.; Dutta, L.; Xu, C.; Keefe, S.; Lee, J.; Pignata, S.Item ENGOT-Ov65/KEYNOTE-B96: Phase III, Randomized, Double-Blind Study Of Pembrolizumab Vs Placebo Plus Paclitaxel With Optional Bevacizumab For Platinum-Resistant Recurrent Ovarian Cancer(2022) Colombo, N.; Coleman, R. L.; Wu, X.; Kose, F.; Wenham, R.; Sebastianelli, A.; Hasegawa, K.; Zsiros, E.; Rouge, T. De La Motte; Bidzinski, M.; McNeish, I.; Sehouli, J.; Korach, J.; Debruyne, P. R.; Kim, J-W.; De Melo, A. C.; Peng, X.; Bogusz, A. M.; Yamada, K.; Monk, B. J.